Market Research Reports and Industry Reports

Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Neurostimulation] - Forecasts till 2019

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
The internal neuromodulation market in Saudi Arabia, South Africa, and Turkey is a fast emerging market. The growth of this market is driven by factors such as public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and the increasingly aging population. However, factors such as the disadvantages of a dearth of skilled professional and the reimbursement scenario restrain the growth of this market.

The report has been broadly classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric neurostimulation. The spinal cord stimulator segment is further categorized on the basis of application into chronic pain, failed back surgery syndrome, ischemic pain, and others. Likewise, the deep brain stimulation market has its application in Parkinsons disease, tremors, depression, and others that include chronic pain, dystonia, Tourettes syndrome, and Alzheimers disease.

The sacral nerve stimulation market has applications in urinary incontinence and fecal incontinence. Vagus nerve stimulator comprises epilepsy and other applications; gastric stimulation includes gastroparaeisis and others. The gastric neurostimulator market segment is estimated to grow at the highest CAGR from 2014 to 2019. The drivers for this market are the increase in the number of people who suffer from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which is a major opportunity for players in this segment.

The market is estimated to be dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Aleva Neurotherapeutics SA (U.S.) Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the internal neuromodulation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various applications of particular modalities of the internal neuromodulation market. The in-depth industry analysis of drivers, inhibitors, and industry trends has been captured in the report. The report also presents the therapy/modality market share analysis of top players country-wise and the company profiles of major companies of the market. It comprises and discusses the rudimentary views on the competitive landscape, emerging- and high-growth segments of the internal neuromodulation market, high-growth regions & countries & their respective regulatory policies.

The report will enrich both the established firms as well as new entrants/smaller firms. It gauges the pulse of the market, which in turn will help the firms garner the larger market share and better market presence. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share/presence.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on internal neurostimulation/neuromodulation modalities offered by the top 10 players in the market

Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the internal neuromodulation market
1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 9
1.2 MARKET SEGMENTATION & COVERAGE 9
1.3 STAKEHOLDERS 10
2 RESEARCH METHODOLOGY 11
2.1 INTEGRATED ECOSYSTEM OF INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET 11
2.2 ARRIVING AT THE neuromostimulation/neuromodulation MARKET SIZE 12
2.2.1 MARKET SHARE 12
2.2.2 TOP-DOWN APPROACH 12
3 EXECUTIVE SUMMARY 13
4 MARKET OVERVIEW 15
4.1 INTRODUCTION 15
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET 15
4.3 MARKET DRIVERS and INHIBITORS 17
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY 20
5.1 INTRODUCTION 20
5.2 SPINAL CORD STIMULATION 23
5.3 DEEP BRAIN STIMULATION 25
5.4 SACRAL NERVE STIMULATION 27
5.5 VAGUS NERVE STIMULATON 29
5.6 GASTRIC ELECTRICAL STIMULATION (GES) 30
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET,BY APPLICATION 33
6.1 INTRODUCTION 33
6.1.1 SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION/ GEOGRAPHY 33
6.1.1.1 Spinal Cord Stimulation (SCS) Market, by Application 34
6.1.1.2 Spinal Cord Stimulation (SCS) Market, by Geography 37
6.1.2 DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION/ GEOGRAPHY 40
6.1.2.1 Deep Brain Stimulation (DBS) Market, by Application 41
6.1.2.2 Deep Brain Stimulation (DBS) Market, by Geography 44
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION/ GEOGRAPHY 47
6.1.3.1 Sacral Nerve Stimulation (SNS) Market, by Application 48
6.1.3.2 Sacral Nerve Stimulation (SNS) Market, by Geography 51
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION/GEOGRAPHY 53
6.1.4.1 Vagus Nerve Stimulation (VNS) Market, by Application 54
6.1.4.2 Vagus Nerve Stimulation (VNS) Market, by Geography 57
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION/ GEOGRAPHY 58
6.1.5.1 Gastric Electrical Stimulation (GES) Market, by Application 59
6.1.5.2 Gastric Electrical Stimulation (GES) Market, by Geography 62
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE 63
7.1 Company share analysis: by Modality 63
7.1.1 SPINAL CORD STIMULATION 63
7.1.2 DEEP BRAIN STIMULATION 65
7.1.3 SACRAL NERVE STIMULATION 66
7.1.4 VAGUS NERVE STIMULATION 66
7.2 COMPANY PRESENCE IN internal neurostimulation/ neuromodulationMARKET 68
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY COMPANY 69
8.1 BOSTON SCIENTIFIC CORPORATION (U.S.) 69
1.1.1. OVERVIEW 69
1.1.2. KEY FINANCIALS: 69
1.1.3. PRODUCT AND SERVICE OFFERINGS 70
1.1.4. RELATED DEVELOPMENTS 70
8.2 CERBOMED GMBH (GERMANY) 71
8.2.1 OVERVIEW 71
8.2.2 KEY FINANCIALS 71
8.2.3 PRODUCT AND SERVICE OFFERINGS 71
8.3 CYBERONICS, INC. (U.S.) 72
8.3.1 OVERVIEW 72
8.3.2 KEY FINANCIALS 72
8.3.3 PRODUCT AND SERVICE OFFERINGS 72
8.4 ENTEROMEDICS, INC. (U.S.) 73
8.4.1 OVERVIEW 73
8.4.2 KEY FINANCIALS 73
8.4.3 PRODUCT AND SERVICE OFFERINGS 73
8.5 MEDTRONIC, INC. (U.S.) 74
8.5.1 OVERVIEW 74
8.5.2 KEY FINANCIALS 74
8.5.3 PRODUCT AND SERVICE OFFERINGS 75
8.5.4 RELATED DEVELOPMENTS 76
8.6 ST. JUDE MEDICAL (U.S.) 77
8.6.1 OVERVIEW 77
8.6.2 KEY FINANCIALS 77
8.6.3 PRODUCT AND SERVICE OFFERINGS 78
8.6.4 RELATED DEVELOPMENTS 79
8.7 SYNAPSE BIOMEDICAL, INC. (U.S.) 80
8.7.1 OVERVIEW 80
8.7.2 KEY FINANCIALS 80
8.7.3 PRODUCT AND SERVICE OFFERINGS 80
8.8 UROPLASTY, INC. (U.S.) 81
8.8.1 OVERVIEW 81
8.8.2 KEY FINANCIALS 81
8.8.3 PRODUCT AND SERVICE OFFERINGS 81
9 APPENDIX 82
9.1 CUSTOMIZATION OPTIONS 82
9.1.1 PRODUCT ANALYSIS 82
9.1.2 EPIDEMIOLOGY DATA 82
9.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 82
9.1.4 REGULATORY FRAMEWORK 82
9.2 RELATED REPORTS 83
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 83
9.3.1 SNAPSHOTS 84

List Of Tables

TABLE 1 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 2019 (USD MILLION) 16
TABLE 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 17
TABLE 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN SAUDI ARABIA, SOUTH AFRICA, AND TURKEY: DRIVERS AND INHIBITORS 17
TABLE 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA,
BY MODALITY, 2013 - 2019 (USD THOUSAND) 20
TABLE 5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY,
BY MODALITY, 2012 2019 (USD THOUSAND) 21
TABLE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA,
BY MODALITY, 2012 2019 (USD THOUSAND) 22
TABLE 7 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,20132019 (USD THOUSAND) 24
TABLE 8 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,20122019 (USD THOUSAND) 26
TABLE 9 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,20132019 (USD THOUSAND) 28
TABLE 10 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY,20122019 (USD MN) 29
TABLE 11 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY,
20132019 (USD THOUSAND) 31
TABLE 12 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION,
2012 2019 (USD THOUSAND) 35
TABLE 13 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 36
TABLE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION,
2012 2019 (USD THOUSAND) 37
TABLE 15 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 38
TABLE 16 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 39
TABLE 17 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 40
TABLE 18 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION,
2012 2019 (USD THOUSAND) 42
TABLE 19 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 43
TABLE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION,
2012 2019 (USD THOUSAND) 44
TABLE 21 PARKINSONS DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 45
TABLE 22 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 46
TABLE 23 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND) 47
TABLE 24 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 2019 (USD THOUSAND) 48
TABLE 25 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 49
TABLE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 2019 (USD THOUSAND) 50
TABLE 27 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 51
TABLE 28 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 52
TABLE 29 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 2019 (USD THOUSAND) 54
TABLE 30 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 55
TABLE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA,BY APPLICATION,
2012 2019 (USD THOUSAND) 56
TABLE 32 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 57
TABLE 33 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA,
BY APPLICATION, 2012- 2019 (USD THOUSAND) 59
TABLE 34 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY,BY APPLICATION,
2012 2019 (USD THOUSAND) 60
TABLE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA,
BY APPLICATION, 2012 2019 (USD THOUSAND) 61
TABLE 36 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 62
TABLE 37 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS, BY SEGMENTS,
2009 2013 (USD MILLION) 69
TABLE 38 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 2012 (USD MILLION) 70
TABLE 39 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION) 72
TABLE 40 MEDTRONIC, INC. : KEY FINANCIALS, BY SEGMENTS, 2009 - 2013 (USD MILLION) 74
TABLE 41 MEDTRONIC, INC. : KEY FINANCIALS, 2009 - 2013 (USD MILLION) 75
TABLE 42 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENTS, 2011 - 2013 (USD MILLION) 77
TABLE 43 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY,2008 - 2013 (USD MILLION) 77
TABLE 44 UROPLASTY, INC. : KEY FINANCIALS, BY GEOGRAPHY,2011 - 2013 (USD MILLION) 81

List Of Figures

FIGURE 1 NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA,
SOUTH AFRICA, AND TURKEY: SEGMENTATION & COVERAGE 10
FIGURE 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM 11
FIGURE 3 TOP-DOWN APPROACH 12
FIGURE 4 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 2018 (USD MILLION) 15
FIGURE 5 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 16
FIGURE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA,
BY MODALITY, 20132019 (USD THOUSAND) 21
FIGURE 7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY,
BY MODALITY, 20132019 (USD THOUSAND) 22
FIGURE 8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY,
BY MODALITY, 20132019 (USD THOUSAND) 23
FIGURE 9 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,20132019 (USD THOUSAND) 24
FIGURE 10 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,20132019 (USD THOUSAND) 26
FIGURE 11 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,20132019 (USD THOUSAND) 28
FIGURE 12 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY, 20132019 (USD MN) 30
FIGURE 13 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY,
20132019 (USD THOUSAND) 32
FIGURE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION,
2012 2019 (USD THOUSAND) 34
FIGURE 15 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 35
FIGURE 16 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION,
2012 2019 (USD THOUSAND) 36
FIGURE 17 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 37
FIGURE 18 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 38
FIGURE 19 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 39
FIGURE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION,
2012 2019 (USD THOUSAND) 41
FIGURE 21 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 42
FIGURE 22 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION,
2012 2019 (USD THOUSAND) 43
FIGURE 23 PARKINSONS DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 44
FIGURE 24 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 45
FIGURE 25 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 46
FIGURE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 2019 (USD THOUSAND) 48
FIGURE 27 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 49
FIGURE 28 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 2019 (USD THOUSAND) 50
FIGURE 29 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 51
FIGURE 30 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 52
FIGURE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 2019 (USD THOUSAND) 54
FIGURE 32 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 55
FIGURE 33 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA, BY APPLICATION,
2012 2019 (USD THOUSAND) 56
FIGURE 34 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 57
FIGURE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA,
BY APPLICATION, 2012 2019 (USD THOUSAND) 59
FIGURE 36 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY, BY APPLICATION,
2012 2019 (USD THOUSAND) 60
FIGURE 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 2019 (USD THOUSAND) 61
FIGURE 38 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET,
BY GEOGRAPHY, 2012 2019 (USD THOUSAND) 62
FIGURE 39 SOUTH AFRICA : SPINAL CORD STIMULATION , BY COMPANY, 2014 63
FIGURE 40 SAUDI ARABIA : SPINAL CORD STIMULATION , BY COMPANY, 2014 64
FIGURE 41 TURKEY : SPINAL CORD STIMULATION , BY COMPANY, 2014 64
FIGURE 42 SOUTH AFRICA : DEEP BRAIN STIMULATION , BY COMPANY, 2014 65
FIGURE 43 SAUDI ARABIA : DEEP BRAIN STIMULATION , BY COMPANY, 2014 65
FIGURE 44 TURKEY : DEEP BRAIN STIMULATION , BY COMPANY, 2014 66
FIGURE 45 SOUTH AFRICA : VAGUS NERVE STIMULATION , BY COMPANY, 2014 66
FIGURE 46 SAUDI ARABIA : VAGUS NERVE STIMULATION , BY COMPANY, 2014 67
FIGURE 47 TURKEY : VAGUS NERVE STIMULATION , BY COMPANY, 2014 67
FIGURE 48 INTERNAL NEUROSTIMULATION/ NEUROMODULATIONMARKET: COMPANY COVERAGE, BY PRODUCT, 2013 68

Mitsui E&P Middle East B.V Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Mitsui E&P Middle East B.V Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Kuwait And Middle East Financial Investment Company Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Kuwait And Middle East Financial Investment Company Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in

USD 200View Report

LCPS – Brambleton Middle School Development – Virginia - Construction Project Profile

Synopsis LCPS Brambleton Middle School Development Virginia contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives

USD 75View Report

Mitsui E&P Middle East B.V Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Mitsui E&P Middle East B.V Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Kuwait And Middle East Financial Investment Company Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Kuwait And Middle East Financial Investment Company Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in

USD 200View Report

Aladdin Middle East, Ltd Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Aladdin Middle East, Ltd Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2650
  • Corporate Licence    $ 4505
$ 2650

Reports Details

Published Date : Feb 2015
No. of Pages :85
Country :Middle East and Africa
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment